2024 Abstract Info Below - 2025 Info Coming Soon

The Symposium on Advanced Wound Care (SAWC) invites you to submit an abstract for consideration to be presented as a poster at the Marriott World Center in Orlando, Florida, May 14–18, 2024. This is your opportunity to share your cutting-edge research with the best-in-class audience of experts in the field.  

Posters will be on display during all poster hall hours and on multimedia screens. ePosters will also be available to view in the mobile app.  

Late Breaking Abstracts

Late-breaking abstracts (LBAs) recognize novel, critically important research developments that occur during the lead-up to SAWC Spring.  LBA submission is solely for abstracts with late-breaking data and not for abstracts submitted “late”. The late-breaking abstract deadline is not intended to be an extension of the general submission deadline. Late-breaking abstracts highlight novel and practice-changing studies, and only apply to data that would have not otherwise have been presented as an abstract at the SAWC Spring | WHS 2024 meeting.

Four abstracts will be showcased during the "Late Breaking Abstracts: Bringing New Evidence to Light,"  session taking place Saturday, May 18th. Submit your late-breaking abstract by March 20, 2024.

A late-breaking abstract should contain new information. It may comprise:

  • either results that were not yet known, or fully available, on the regular abstract submission deadline.
  • or work that has been submitted for publication.

If a late-breaking abstract is not accepted, it will not be published or presented at the meeting. There is no longer an option for it to be considered as a regular abstract.

Late-Breaking Abstracts will be considered for the SAWC Spring | WHS 2024 meeting if they fulfill the following criteria:

  • The topic must be of critical importance to the clinical/scientific wound healing community.
  • The abstract must report data that became available for public dissemination only after the deadline of the regular abstract submission (January 3, 2024), and has not been previously published or presented.
  • The study and results reported should be novel (not simply an extension of previously published work) or be definitive of confirming or refuting other critically important work.
  • The following categories are typically suited to the main poster sessions and will not be considered for late-breaking abstracts: case studies, reviews of existing treatments, etc.
  • LBA submission is solely for abstracts with late-breaking data and not for abstracts submitted “late”. The late-breaking abstract deadline is not intended to be an extension of the general submission deadline.

Abstract Presentations

You may select one of the three presentation types for consideration:

Additionally, you may also select to be considered for:

Key Dates for Submissions

  • Abstract Submission Site Opens: October 30, 2023
  • Abstract Submission Site Closes: January 3, 2024
  • Notification of Acceptance or Rejection: February 2, 2024
  • Withdrawal Date: February 26, 2024
  • Registration and Intent to Present Due: February 16, 2024
  • Late-Breaking Abstract Submission Site Opens: February 21, 2024
  • Late-Breaking Abstract Submission Site Closes: March 20, 2024
  • Notification of Late-Breaking Abstract Acceptance or Rejection: April 3, 2024
  • Late-Breaking Abstract Intent to Present Due: April 17, 2024
  • PDF Posters Due: April 15, 2024

*Deadlines are tentative and subject to change 

Submission Categories

  • Case Series/Case Study
  • Clinical Research
  • Evidence-Based Practice
  • Health Economics
  • Laboratory Research
  • Practice Innovation

Important Information

Click below for information on:

Please note that expenses associated with the submission and presentation of an abstract are the responsibility of the presenter and may include hotel, travel, and meeting registration.

Acceptance and Correspondence

Primary Contact

All abstract communications will be sent to the primary contact (submitter). The primary contact will be responsible for notifying all authors of important details and deadlines. Please save abstractsubmissions@hmpglobal.com to your address book so that you do not miss important correspondence. Additionally, the website will be updated with any important dates or instructions. We are not responsible for any emails that are not received due to misspellings, defunct email accounts, or blocked emails from abstractsubmissions@hmpglobal.com.

Disposition/Notification of Acceptance

Abstracts will be accepted on a competitive basis. The acceptance/rejection notification email will be sent to the primary contact (submitter). Please do not inquire about the status of your submission before the date noted at the top of this page, as no further information will be available. Prior to the meeting, all information will be forwarded to the primary contact only, and they are responsible for notifying all other authors of upcoming details.

Intent to Present

SAWC requires proof of preregistration for all accepted abstract presenters. After registering, it is the designated primary contact’s responsibility to indicate their intent to present through the abstract portal, as outlined in acceptance email, by providing the badge number of the registered representative. The badge number can be found on your registration confirmation. Instructions on this process will be included in your acceptance email. Even though you may be registered for SAWC, intent to present must still be submitted. If the intent to present is not submitted by the date included in your acceptance email, the abstract will be withdrawn. 


Please review the below additional documents before contacting the SAWC Abstract Team with questions.

If you have questions not answered in the above documents, please email abstractsubmissions@hmpglobal.com.